Deep Track Capital, LP Context Therapeutics Inc. Transaction History

Deep Track Capital, LP

  • $2.82 Billion
  • Q2 2025

A detailed history of Deep Track Capital, LP transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 7,419,355 shares of CNTX stock, worth $8.16 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
7,419,355
Previous 7,419,355 -0.0%
Holding current value
$8.16 Million
Previous $4.53 Million 8.2%
% of portfolio
0.17%
Previous 0.16%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$1.24 - $2.19 $9.2 Million - $16.2 Million
7,419,355 New
7,419,355 $14.8 Million

About Context Therapeutics Inc.

CNTX Quotes by TradingView
  • Ticker CNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,966,100
  • Market Cap $17.6M
  • Description
  • Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...
More about CNTX
Track This Portfolio

Track Deep Track Capital, LP Portfolio

Follow Deep Track Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Deep Track Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email